IPSNEWS
How to classify a cosmetic product in Mexico: a regulatory case study
One of the most common mistakes when introducing a cosmetic product into the Mexican market is assuming that its regulatory classification depends solely on its formulation.
In this article, we analyze a case study that reflects a common situation faced by international manufacturers seeking to introduce cosmetic products into the Mexican market.
New COFEPRIS Guide: Optimization and agility in the Sanitary Registration of Medical Devices
Seeking to unify current Equivalence Agreements and the Abbreviated Regulatory Pathway, the Federal Commission for Protection against Sanitary Risks (COFEPRIS) has published the Requirements Guide for the Sanitary Registration of Medical Devices.
Dietary Supplement classification: Scope of the new COFEPRIS Guide
COFEPRIS has published the "Non-Regulatory Guide for the Classification of Products as Dietary Supplements." This technical document compiles the requirements of national legislation through a self-assessment format and a decision-making diagram to determine whether a product belongs in this category.
RAUpdate: Prohibition of Erythrosine (Red 3 FD&C) in the Mexican Food Industry
The Mexican Ministry of Health (Secretaría de Salud) has issued an Agreement to eliminate the use of the coloring agent Erythrosine and its lakes (Red 3 FD&C) in food, beverages, and dietary supplements. This measure responds to a risk analysis that determined that the population's exposure exceeds internationally established safety limits.
RAUpdate New NOM-137-SSA1-2025: Requirements for Medical Device labeling in Mexico
On May 19, 2026, Mexico's Ministry of Health published the new NOM-137-SSA1-2025 in the Official Gazette of the Federation (DOF), which completely replaces the version in force since 2008.
Dietary Supplement labeling: COFEPRIS compliance guide
This article details the technical and legal requirements that must be met by labels for dietary supplements marketed in Mexico. Its objective is to provide manufacturers, importers, and distributors with a clear roadmap to ensure their products present truthful information, avoiding omissions that compromise transparency toward the consumer. The correct implementation of these elements ensures that the product remains within the current sanitary legal framework before COFEPRIS.
RAUpdate Administrative modernization of COFEPRIS: Streamlining procedures
The administrative reform published on May 4, 2026, is focused on the digitalization and operational efficiency of The Federal Commission for Protection against Sanitary Risks (COFEPRIS). The analysis covers the elimination of physical requirements, the consolidation of procedure codes (homoclaves) regarding advertising, and the acceleration of medical device procedures.
Storage and distribution of dietary supplements under NOM-251-SSA1-2009
In the dietary supplement industry, storage is not merely the safeguarding of merchandise; it is a vital link in the value chain that guarantees the safety and efficacy of the final product. For distribution companies in Mexico, compliance with NOM-251-SSA1-2009 is both a legal and ethical obligation.
RAUpdate: Creation of the CENAFyT and its impact on the health sector.
On March 9, 2026, COFEPRIS officially announced the creation of the National Center for Pharmacovigilance and Technovigilance (CENAFYT). This body emerges not as an isolated entity, but as the strategic evolution of the former National Pharmacovigilance Center (CNFV), following the legal modifications made to the General Health Law at the beginning of 2026.
Ingredient regulatory framework for dietary supplements in Mexico: A compliance guide
This article details the legal and sanitary framework governing permitted and prohibited ingredients in the formulation of dietary supplements in Mexico. It addresses questions regarding the technical viability of formulas, limits on additives, vitamins, minerals, and botanical extracts to avoid sanctions, customs seizures, or product redesigns.